Inger Brandt
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
-
- Neuropeptides and Animal Physiology
Papers in
-
- Neuropeptides and Animal Physiology 7
- Oncology 8
- Peptidase Inhibition and Analysis 8
- Co-authors
- Anne‐Marie Lambeir (9 shared papers)Ingrid De Meester (8 shared papers)Simon Scharpé (5 shared papers)Simon Scharpé (4 shared papers)Marie-Berthe Maes (4 shared papers)Marc Vanderheyden (2 shared papers)Jean‐Marie Ketelslegers (1 shared paper)Koen Augustyns (5 shared papers)
- Journals
- Peptides (2 papers)Clinica Chimica Acta (2 papers)Journal of Neurochemistry (1 paper)Journal of Leukocyte Biology (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- BelgiumTaiwanNetherlands
In The Last Decade
Inger Brandt
16 papers receiving 669 citations
Peers
Comparison fields: 5 of 79
- Oncology 391
- Cellular and Molecular Neuroscience 243
- Endocrinology, Diabetes and Metabolism 199
- Cardiology and Cardiovascular Medicine 81
- Physiology 17
Countries citing papers authored by Inger Brandt
This map shows the geographic impact of Inger Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Brandt more than expected).
Fields of papers citing papers by Inger Brandt
This network shows the impact of papers produced by Inger Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Brandt. The network helps show where Inger Brandt may publish in the future.
Co-authors
The 25 scholars most cited alongside Inger Brandt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 159 | |
| 2 | 2005 | 107 | |
| 3 | 2008 | 77 | |
| 4 | 2006 | 75 | |
| 5 | 2007 | 55 | |
| 6 | 2007 | 44 | |
| 7 | 2005 | 32 | |
| 8 | 2008 | 29 | |
| 9 | 2008 | 25 | |
| 10 | 2011 | 25 | |
| 11 | 2006 | 25 | |
| 12 | 2015 | 16 | |
| 13 | 2019 | 10 | |
| 14 | 2016 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 1954 | 4 |
About Inger Brandt
Inger Brandt is a scholar working on Cellular and Molecular Neuroscience, Oncology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Neurology, having authored 16 papers that have together received 692 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Neuropeptides and Animal Physiology (7 papers), Diabetes Treatment and Management (3 papers), Signaling Pathways in Disease (2 papers), Protease and Inhibitor Mechanisms (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Botany and Plant Ecology Studies (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Oncology (391 citations), Cellular and Molecular Neuroscience (243 citations), Endocrinology, Diabetes and Metabolism (199 citations), Cardiology and Cardiovascular Medicine (81 citations) and Physiology (17 citations). Inger Brandt has collaborated with scholars based in Belgium, Taiwan and Netherlands. Frequent co-authors include Anne‐Marie Lambeir, Ingrid De Meester, Simon Scharpé, Simon Scharpé, Marie-Berthe Maes, Marc Vanderheyden, Jean‐Marie Ketelslegers, Koen Augustyns, Xin Chen and Jurgen Joossens. Their work appears in journals such as Peptides, Clinica Chimica Acta, Journal of Neurochemistry, Journal of Leukocyte Biology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.